Digital The right AI for the right job, with Iya Khalil In a post-BIO virtual interview, Jonah Comstock speaks with Iya Khalil, VP and head of data, AI, and genome sciences at Merck & Co (MSD in Europe).
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.